1 |
BTNL2, a Novel T Cell Coinhibitory Molecule, as a Therapeutic Target in Ulcerative Colitis |
DBT, NEW DELHI |
PI: Gayatri Mukherjee |
2 |
Development of Antigen specific Cell-free and Cell-based Novel Immunotherapeutic Strategies in Cancer |
Science and Engineering Research Board (SERB) |
PI: Gayatri Mukherjee |
3 |
MHC Haplotypes in HBE/Beta Thalassemia: Correlating Disease Heterogeneity and Blood Transfusion Requirements in West Bengal |
Department of Science and Technology and Biotechnology |
Consultants: Gayatri Mukherjee |
4 |
Development of Cell-free Peptide-MHC Based Immunotherapeutic Reagent to Manipulate Cytotoxic T Cells in Cancer |
ISIRD, SRIC |
PI: Gayatri Mukherjee |